Alimera Sciences Sues ANI Pharmaceuticals for Delays in Merger Close

MT Newswires Live
2024/09/11

Alimera Sciences (ALIM) said Tuesday it filed a lawsuit in the Delaware Court of Chancery to force ANI Pharmaceuticals (ANIP) to complete their merger.

"Alimera has fulfilled all its requirements to close the merger agreement, yet ANI has failed to adhere to its obligation to close on time," the company added.

ANI said Tuesday it is working in good faith to complete the transaction and plans to promptly resolve any delays resulting from discussions about the closing conditions.

ANI agreed to acquire Alimera in June in a deal valued at around $381 million.

Alimera and ANI shares were down 6.7% and 5.3% in recent trading, respectively.

Price: 5.16, Change: -0.40, Percent Change: -7.12

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10